Skip to content
PeptideTech
sign in
live116 compounds · 15 vendors listed · 7 graded · audit of 4 Nov 2026 · prices checked 6 Nov 2026independent · grades can’t be bought

Home / Research library / KPV

Peptides

KPV: molecular data, studies & sources

KPV is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular formula (MF)
C16H30N4O4
Molecular weight (MW)
342.43 g/mol
PubChem compound ID
125672
Record title
Msh (11-13)

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 125672 · retrieved 2026-09-21

2D molecular structure for KPV, PubChem CID 125672
2D depiction from PubChem. Open to inspect the full image. This drawing represents the selected record, not a vendor batch test.
Chemical identifiers and source data
IUPAC name
(2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid
InChIKey
YSPZCHGIWAQVKQ-AVGNSLFASA-N
SMILES
CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)N
Machine-readable PubChem source

Identifiers & sequence

PubChem CID
125672
CAS Registry Number
67727-97-3via ChemIDplus, EPA DSSTox
InChIKey
YSPZCHGIWAQVKQ-AVGNSLFASA-N
Wikidata
Q82975228

Peptide sequence · 3 residues (one-letter code; X marks a residue without a one-letter code)

KPV

Condensed notation with terminal groups and non-standard residues

H-Lys-Pro-Val-OH

Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.

CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.

Calculated molecular descriptors
Monoisotopic (exact) mass342.2267 Da
Heavy atoms24
Hydrogen-bond donors4
Hydrogen-bond acceptors5
Rotatable bonds9
Topological polar surface area138.8 Ų
Calculated logP (Crippen)-0.34
Rings1
Stereocenters3
Formal charge0

Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.

Registered clinical trials

Studies registered on ClinicalTrials.gov that list KPV as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human intervention studies

Selected studies in which participants received KPV, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

    Preclinical research, reviews & other publications

    Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

    1. Research publication · design requires review

      alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.

      Elliott RJ, Szabo M, Wagner MJ et al. · The Journal of investigative dermatology · 2004

      PMID 15102092 · DOI: 10.1111/j.0022-202X.2004.22404.x

    2. Preclinical / laboratory research

      A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.

      Zhao Y, Xue P, Lin G et al. · Acta biomaterialia · 2022

      PMID 35245681 · DOI: 10.1016/j.actbio.2022.02.039

    3. Research publication · design requires review

      Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.

      Pawar K, Kolli CS, Rangari VK et al. · Journal of pharmaceutical sciences · 2017

      PMID 28343991 · DOI: 10.1016/j.xphs.2017.03.017

    4. Preclinical / laboratory research

      Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.

      Getting SJ, Schiöth HB, Perretti M et al. · The Journal of pharmacology and experimental therapeutics · 2003

      PMID 12750433 · DOI: 10.1124/jpet.103.051623

    5. Research publication · design requires review

      KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.

      Zhang L, Li D, Aierken Y et al. · Advanced healthcare materials · 2024

      PMID 39252648 · DOI: 10.1002/adhm.202402320

    6. Research publication · design requires review

      PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

      Dalmasso G, Charrier-Hisamuddin L, Nguyen HT et al. · Gastroenterology · 2007

      PMID 18061177 · DOI: 10.1053/j.gastro.2007.10.026

    7. Preclinical / laboratory research

      Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.

      Kannengiesser K, Maaser C, Heidemann J et al. · Inflammatory bowel diseases · 2008

      PMID 18092346 · DOI: 10.1002/ibd.20334

    8. Preclinical / laboratory research

      Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats.

      Sun J, Xue P, Liu J et al. · ACS biomaterials science & engineering · 2021

      PMID 34547895 · DOI: 10.1021/acsbiomaterials.1c00792

    KPV supplier sources

    Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

    KPV for sale: compare prices, sizes and forms from every tracked supplier →

    SupplierRecorded packagesExample source listing
    American PeptidesUSD10mg Vial1 recorded offers10mg Vial · $60.00Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, American Peptides, opens in a new tab
    Blank PeptidesUSD10mg Vial1 recorded offers10mg Vial · $45.00Stale observation · Checked Sep 30, 2026Supplier listing, KPV 10mg Vial, Blank Peptides, opens in a new tab
    Amino ClubUSD10mg Vial1 recorded offers10mg Vial · $39.99Stale observation · Checked Oct 14, 2026Supplier listing, KPV 10mg Vial, Amino Club, opens in a new tab
    Nova Peptide SupplyUSD10mg Vial1 recorded offers10mg Vial · $49.99Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, Nova Peptide Supply, opens in a new tab
    Amino USAUSD10mg Vial · 5mg Vial2 recorded offers10mg Vial · $50.00Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, Amino USA, opens in a new tab
    Cenexa LabsUSD10mg Vial1 recorded offers10mg Vial · $69.99Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, Cenexa Labs, opens in a new tab
    LA PeptidesUSD10mg Vial1 recorded offers10mg Vial · $59.99Checked Nov 3, 2026Supplier listing, KPV 10mg Vial, LA Peptides, opens in a new tab

    Reference sources & further reading

    The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

    Search for additional research

    These links run searches; their results have not been individually reviewed and can include unrelated compounds.

    Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

    Related research profiles

    Peptides

    ARA-290

    C51H84N16O21

    1257.3 g/mol · PubChem CID 91810664

    7 selected publications · 3 human intervention studies · 2 registered trials

    Protein / peptide · highest stage: Phase 2

    Structure, studies & sources →

    Peptides

    BPC-157

    C62H98N16O22

    1419.5 g/mol · PubChem CID 9941957

    7 selected publications · 1 human intervention study · 3 registered trials

    Protein / peptide · highest stage: Phase 1

    Structure, studies & sources →